Allied Market Research

2024

Amoxicillin Market

Amoxicillin Market Size, Share, Competitive Landscape and Trend Analysis Report by Therapy Type, by Indication, by Distribution Channel : Global Report opportunity Analysis and Industry Forecast, 2023-2033

LS : Pharmaceuticals

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Amoxicillin is a type of antibiotic that can be used to treat a number of bacterial infections. These include mainly middle ear infection, strep throat, pneumonia, also skin infections, and other urinary tract infections, among others. Furthermore, it is taken by mouth, or less commonly by injection. Common adverse effects include rash and nausea. It may also boost the risk of yeast infections and when used in combination with clavulanic acid, may cause diarrhea. This should not be used in those who are allergic to penicillin. In addition, it is usable in those with kidney problems, the dose may need to be reduced. The use of Amoxicillin in pregnancy and breastfeeding does not appear to be much harmful.

COVID-19 scenario analysis:

The Pharmaceutical and biotech companies have joined together with governments around the globe in order to manage COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Furthermore there is various development initiatives carried out such that around 115 vaccine candidates and 155 molecules are expected to help in management of coronavirus disease -2. Moreover, the drugs which are successfully showing its effect on the patient such as Hydroxychloroquine have witnessed dramatic surge in demand for the management of COVID-19. The high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. The rise in demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The major factor affecting the market includes the rise in the incidences of various infectious diseases such as urinary tract infections, chest infection and other bacterial infections would boost the industry in the forecast period. The increase in awareness of the infectious diseases is anticipated to propel the market growth in the coming years. The key advantages offered by amoxicillin is anticipated to help the industry grow in the near future. However, the stringent regulations over the medications would impede the market growth in the near future.

Rise in incidence of infectious disease to flourish the market

According to the National Kidney Foundation, One in five women will have at least one UTI in her lifetime. Nearly 20 percent of women who have a UTI are anticipated to have another and 30 percent of those will have yet another. Of this last group, 80 percent will have recurrences.

According to the Center for Disease Control and Prevention, the estimated number of deaths due to pneumonia are about 49, 157 and the ration of the population of deaths include, 15.1 in 100,000. The increase in population experiencing infections would propel the market.

Surge in number of definitive agreements to boost the market

In October 2016, Vernalis Therapeutics, Inc. announced that it has begun promoting MOXATAG (amoxicillin extended-release) tablets to primary care physicians in the U.S. MOXATAG is the first and only approved once-daily formulation of the widely-used antibiotic amoxicillin.

Key benefits of the report:

  • This study presents the analytical depiction of the global Amoxicillin industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global market share.
  • The current market is quantitatively analyzed to highlight the global market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Amoxicillin Market research report:

  • Who are the leading market players active in the Amoxicillin market?
  • What are the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in tasking further strategic steps?

Amoxicillin Market Report Highlights

Aspects Details
icon_5
By Therapy Type
  • Monotherapy
  • Combinational Therapy
icon_6
By Indication
  • Respiratory Tract Infection
  • Skin Infection
  • Chest Infection
  • Ear Infection
  • Urinary Tract Infection
  • Bacterial Endocarditis
  • Others
icon_7
By Distribution Channel
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
icon_8
By Region
  • North America  (U.S.)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
icon_9
Key Market Players

TEVA PHARMACEUTICALS INDUSTRIES LTD, NOVARTIS AG (SANDOZ), West-Ward Pharmaceuticals, Hikma Pharmaceuticals Plc, Sun Pharmaceuticals Industries Ltd, NorthStar Rx LLC, Dr. Reddy's Laboratories Ltd, Glaxosmithkline Plc, Bremer Pharma GmbH, Aurobindo Pharma Limited

Key Market Players
Other Players

Pfizer, Inc

Related Tags

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Amoxicillin Market

Global Report opportunity Analysis and Industry Forecast, 2023-2033